TLDR Statins do not impact BPH and LUTS progression when combined with finasteride.
The study investigated whether statins had any impact on the progression of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) when combined with finasteride. The research aimed to determine if the combination therapy could offer additional benefits over finasteride alone. However, the document did not provide specific details on the number of participants or the outcomes of the study, making it difficult to draw definitive conclusions from the summary provided.
13 citations
,
December 2012 in “Canadian Urological Association Journal” 5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.
15 citations
,
July 2016 in “Urologic Clinics of North America” Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.
1 citations
,
November 2015 in “Cochrane library” 5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.
19 citations
,
October 2018 in “PLOS ONE” 5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.
11 citations
,
January 2018 in “Asian Journal of Andrology” Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.
3 citations
,
March 2020 in “The Journal of Urology” Older patients sticking to their prostate medication saw lasting health benefits.